Brazil to import two million AstraZeneca vaccine doses, not yet approved for use

Brazil’s health regulator Anvisa said late on Saturday it had approved the import of 2 million doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, although the jab is not yet approved for use in the country.

migrator

Published:3rd Jan, 2021 at 8:10 PM

Anvisa said it approved the importation request from federal government-affiliated biomedical center Fiocruz on Thursday.

Importing the doses prior to approval will enable vaccination to begin as soon as Anvisa okays its use, the regulator said. Brazil has yet to approve any vaccine.

Fiocruz will apply for emergency use of the vaccine by Wednesday, its president, Nísia Trindade, said last week.

Brazil has recorded the second-deadliest outbreak of COVID-19 after only the United States. South America’s largest country has the third highest tally of coronavirus cases, with the health ministry registering more than 7.7 million, after the United States and India.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Brazil to import two million AstraZeneca vaccine doses, not yet approved for use

Brazil’s health regulator Anvisa said late on Saturday it had approved the import of 2 million doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, although the jab is not yet approved for use in the country.

Also Read

All eyes on Governor as House convenes on Jan 20

Air prices skyrocket as demand surges for flights to Kochi

EMUs partially, fully cancelled on December 28

AIADMK extends poll ticket deadline by four days

Protesting SGST teachers arrested; EPS condemns govt inaction